Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pediatrics · Transcobalamin II Deficiency

Transcobalamin II Deficiency: A Patient Guide

At a Glance

Transcobalamin II deficiency is an inherited B12 transport disorder: blood B12 may be normal or high while cells remain deficient. Early, lifelong hydroxocobalamin injections and monitoring of MMA and homocysteine help support blood, immune, and nervous-system development.

Transcobalamin II (TCII) deficiency is an exceptionally rare genetic condition that fundamentally changes how the body processes Vitamin B12. Unlike a typical vitamin deficiency caused by diet, TCII deficiency is a “transport” problem. The body produces a protein—a sort of biological taxi—responsible for carrying Vitamin B12 from the bloodstream into the individual cells where it is needed to build DNA, create healthy blood, and support the nervous system. When this taxi protein is missing or broken due to changes in the TCN2 gene, the “doors” to the cells remain locked. Even if the blood is saturated with Vitamin B12, the cells themselves are functionally deficient [1][2].

Because this is an autosomal recessive condition, it is something inherited from both parents who are usually healthy “carriers” of the gene change. This guide is written primarily for the parents and caregivers of newly diagnosed infants. The impact of this cellular deficiency often appears early in infancy, affecting the systems that grow the fastest: the blood and the immune system. Without enough B12 inside the cells, the body cannot produce enough healthy red blood cells, white blood cells, or antibodies. This can lead to persistent paleness, poor weight gain, and an increased risk of serious infections. Furthermore, B12 is essential for nervous system development; if the cells go without it for too long, it can lead to delays in reaching milestones like sitting up, crawling, or speaking [3][4][5].

The defining characteristic of TCII deficiency is a “biochemical paradox” that can be confusing for families and even some doctors. Standard blood tests may show normal or even very high levels of Vitamin B12, which might suggest there is no problem. However, because that B12 is stuck in the blood and cannot get into the cells, other markers in the body—specifically methylmalonic acid (MMA) and homocysteine—will rise. These two functional markers act as an internal signal, helping the medical team estimate how much B12 is reaching the “inside” of the cells. Managing this condition requires looking past the standard B12 numbers and focusing on individualized, age- and laboratory-specific targets for these markers to ensure the treatment is working [2][6].

While the diagnosis is life-changing, it is a highly treatable condition. The goal of care is to bypass the broken transport system by providing high-dose B12 injections, typically using a form called hydroxocobalamin. By keeping B12 levels in the blood extremely high, the vitamin can enter the cells through alternative pathways, bypassing the locked door. This treatment is a lifelong commitment, but when started early and maintained consistently, it supports biochemical and immune recovery and provides the best opportunity for ongoing development. You are now the lead advocate for your child, sharing responsibility with a team of specialists to ensure they have the consistent support needed to thrive [7][6][8].

Common questions in this guide

What is transcobalamin II deficiency?
It is a rare inherited disorder in which the body cannot move vitamin B12 from the bloodstream into cells. The blood may contain normal or high B12, but cells lack enough B12 for healthy blood production, immune function, and nervous-system development.
Can a normal vitamin B12 level rule out TCII deficiency?
No. In TCII deficiency, serum B12 can be normal or high because the transport protein is not delivering it effectively to cells. Clinicians instead follow functional markers such as methylmalonic acid and homocysteine, using goals individualized to the child and laboratory.
What signs can transcobalamin II deficiency cause in babies?
Babies may develop paleness, poor weight gain, serious infections, or delays in milestones such as sitting, crawling, or speaking. Caregivers should share changes in energy, feeding, or movement with the child's specialist.
How is transcobalamin II deficiency treated?
Treatment usually involves high-dose vitamin B12 injections, often using hydroxocobalamin. The high amount of B12 in the blood can help it enter cells through alternative pathways, and treatment is generally lifelong with ongoing monitoring.
How do doctors know whether the B12 injection dose is working?
The care team can track methylmalonic acid and homocysteine to assess how much B12 is reaching cells and whether treatment is working. A normal serum B12 level by itself does not show whether the child's cells are receiving enough B12.
Why can a baby have TCII deficiency if both parents are healthy?
TCII deficiency is autosomal recessive, meaning a child usually inherits a TCN2 gene change from both parents. Parents often have no symptoms because they carry one changed copy rather than having the condition themselves.
What ongoing care does a child with TCII deficiency need?
Treatment is usually lifelong, with monitoring of functional B12 markers and coordination between the metabolic team and the child's pediatrician. Families may also need an emergency letter to explain the condition and treatment if the child is seen at an unfamiliar hospital.

Get notified when new evidence is published on Transcobalamin deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Genetic polymorphisms of the cobalamin transport system are associated with idiopathic recurrent implantation failure.

    Park HS, Kim JO, An HJ, et al.

    Journal of assisted reproduction and genetics 2019; (36(7)):1513-1522 doi:10.1007/s10815-019-01455-4.

    PMID: 31123954
  2. 2

    Transcobalamin II Deficiency in Four Cases with Novel Mutations.

    Ünal Ş, Rupar T, Yetgin S, et al.

    Turkish journal of haematology : official journal of Turkish Society of Haematology 2015; (32(4)):317-22 doi:10.4274/tjh.2014.0154.

    PMID: 25914105
  3. 3

    Myelodysplasia uncovering transcobalamin deficiency.

    Al Sulaimi K, Al Zaabi A, Wali Y, Al Murshedi FQ

    BMJ case reports 2026; (19(8)) doi:10.1136/bcr-2025-271492.

    PMID: 42613130
  4. 4

    Different Presentations of Patients with Transcobalamin II Deficiency: A Single-Center Experience from Turkey

    Ünal S, Karahan F, Arıkoğlu T, et al.

    Turkish journal of haematology : official journal of Turkish Society of Haematology 2019; (36(1)):37-42 doi:10.4274/tjh.galenos.2018.2018.0230.

    PMID: 30185401
  5. 5

    Transcobalamin II deficiency in twins with a novel variant in the TCN2 gene: case report and review of literature.

    Kose E, Besci O, Gudeloglu E, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(11)):1487-1499.

    PMID: 32841161
  6. 6

    Intramuscular Vitamin B12 Treatment in Transcobalamin II Deficiency: Case Series Clinical Outcomes.

    Sawlan AM, Alotaibi M, Alharbi RM, et al.

    The application of clinical genetics 2025; (18()):73-80 doi:10.2147/TACG.S519631.

    PMID: 40496011
  7. 7

    Identification of transcobalamin deficiency with two novel mutations in the TCN2 gene in a Chinese girl with abnormal immunity: a case report.

    Zhan S, Cheng F, He H, et al.

    BMC pediatrics 2020; (20(1)):460 doi:10.1186/s12887-020-02357-6.

    PMID: 33023511
  8. 8

    New data supporting that early diagnosis and treatment are possible and necessary in intracellular cobalamin depletion: the case of transcobalamin II deficiency.

    Verónica B, Crespo C, Lochner N, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(4)):380-386 doi:10.1515/jpem-2023-0577.

    PMID: 38436354

This page is for informational purposes only and does not constitute medical advice. Your child's metabolic team and pediatrician should guide injection doses, monitoring, and emergency care.